Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study
Mina C. Hosseinipour, Sam Phiri(Lighthouse Trust), Salem Gugsa(University of Washington), Kara Compliment(University of North Carolina at Chapel Hill), Florence Kasende(Dignitas International), Sarah E. Rutstein(University of North Carolina at Chapel Hill), Frank Chimbwandira(Ministry of Health), Erik J Schouten(African Institute for Development Policy), Clement Trapence(Lighthouse Trust), Levison Chiwaula(University of Malawi), Blessings N. Kaunda-Khangamwa(University of Malawi), Fabian Cataldo(Dignitas International), Monique van Lettow(University of Toronto), Hannock Tweya(University of Washington), Virginia Kayoyo, Atupele Kapito–Tembo(University of Malawi), Veena Sampathkumar(Christian Health Association of Malawi), Julie A. Nelson(University of North Carolina at Chapel Hill), Nora E. Rosenberg, Christopher Stanley, Michael Eliya(Ministry of Health)
Cited by 55
Related Papers
HIV-1 infection in a man homozygous for CCR5▵32
|The Lancet|1997|267
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237